drugset

drugset / Trial / NCT04746105

A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.

NCT04746105 ↗

Phase 1 Completed 46 enrolled Taisho Pharmaceutical Co., Ltd.

RandomizedCrossoverDouble-blindTreatment

Summary

A study to evaluate the respiratory safety of TS-142 in patients with mild obstructive sleep apnea hypopnea.

Timeline

Start: 2021-02-24
Primary completion: 2021-10-30
Completion: 2021-10-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TS-142	Small molecule	10 mg	Oral

Indications